24-04-2024 | Epilepsy | Editorial
Novel Mechanism, Drug Target and Therapy in Epilepsy
Published in: Neuroscience Bulletin
Login to get accessPlease log in to get access to this content
Literature
1.
go back to reference Collaborators G2E. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2019, 18: 357–375.CrossRef
Collaborators G2E. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 2019, 18: 357–375.CrossRef
2.
go back to reference Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology 2020, 168: 107966.CrossRefPubMed
Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology 2020, 168: 107966.CrossRefPubMed
3.
go back to reference Xu C, Gong Y, Wang Y, Chen Z. New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments. Pharmacol Ther 2022, 233: 108026.CrossRefPubMed
Xu C, Gong Y, Wang Y, Chen Z. New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments. Pharmacol Ther 2022, 233: 108026.CrossRefPubMed
4.
go back to reference Chen Z, Maturana MI, Burkitt AN, Cook MJ, Grayden DB. High-frequency oscillations in epilepsy: what have we learned and what needs to be addressed. Neurology 2021, 96: 439–448.CrossRefPubMed
Chen Z, Maturana MI, Burkitt AN, Cook MJ, Grayden DB. High-frequency oscillations in epilepsy: what have we learned and what needs to be addressed. Neurology 2021, 96: 439–448.CrossRefPubMed
5.
go back to reference Ye H, Chen C, Weiss SA, Wang S. Pathological and physiological high-frequency oscillations on electroencephalography in patients with epilepsy. Neurosci Bull 2023, https://doi.org/10.1007/s12264-023-01150-6.CrossRefPubMed
Ye H, Chen C, Weiss SA, Wang S. Pathological and physiological high-frequency oscillations on electroencephalography in patients with epilepsy. Neurosci Bull 2023, https://doi.org/10.1007/s12264-023-01150-6.CrossRefPubMed
6.
go back to reference Liu X, Zhang Y, Zhao Y, Zhang Q, Han F. The neurovascular unit dysfunction in the molecular mechanisms of epileptogenesis and targeted therapy. Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01193-3.CrossRefPubMedPubMedCentral
Liu X, Zhang Y, Zhao Y, Zhang Q, Han F. The neurovascular unit dysfunction in the molecular mechanisms of epileptogenesis and targeted therapy. Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01193-3.CrossRefPubMedPubMedCentral
7.
go back to reference Foulsham W, Dohlman TH, Mittal SK, Taketani Y, Singh RB, Masli S. Thrombospondin-1 in ocular surface health and disease. Ocul Surf 2019, 17: 374–383.CrossRefPubMedPubMedCentral
Foulsham W, Dohlman TH, Mittal SK, Taketani Y, Singh RB, Masli S. Thrombospondin-1 in ocular surface health and disease. Ocul Surf 2019, 17: 374–383.CrossRefPubMedPubMedCentral
8.
go back to reference Cheng Y, Zhai Y, Yuan Y, Wang Q, Li S, Sun H. The contributions of thrombospondin-1 to epilepsy formation. Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01194-2.CrossRefPubMed
Cheng Y, Zhai Y, Yuan Y, Wang Q, Li S, Sun H. The contributions of thrombospondin-1 to epilepsy formation. Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01194-2.CrossRefPubMed
9.
go back to reference Xu C, Zhang S, Gong Y, Nao J, Shen Y, Tan B, et al. Subicular caspase-1 contributes to pharmacoresistance in temporal lobe epilepsy. Ann Neurol 2021, 90: 377–390.CrossRefPubMed
Xu C, Zhang S, Gong Y, Nao J, Shen Y, Tan B, et al. Subicular caspase-1 contributes to pharmacoresistance in temporal lobe epilepsy. Ann Neurol 2021, 90: 377–390.CrossRefPubMed
10.
go back to reference Vezzani A, Balosso S, Ravizza T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol 2019, 15: 459–472.CrossRefPubMed
Vezzani A, Balosso S, Ravizza T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol 2019, 15: 459–472.CrossRefPubMed
11.
go back to reference Dong Y, Zhang X, Wang Y. Interleukins in epilepsy: friend or foe. Neurosci Bull 2024, https://doi.org/10.1007/s12264-023-01170-2.CrossRefPubMed
Dong Y, Zhang X, Wang Y. Interleukins in epilepsy: friend or foe. Neurosci Bull 2024, https://doi.org/10.1007/s12264-023-01170-2.CrossRefPubMed
12.
go back to reference Chechneva OV, Mayrhofer F, Daugherty DJ, Pleasure DE, Hong JS, Deng W. Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord. Neurobiol Dis 2011, 44: 63–72.CrossRefPubMedPubMedCentral
Chechneva OV, Mayrhofer F, Daugherty DJ, Pleasure DE, Hong JS, Deng W. Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord. Neurobiol Dis 2011, 44: 63–72.CrossRefPubMedPubMedCentral
13.
go back to reference Yang JJ, Liu YX, Wang YF, Ge BY, Wang Y, Wang QS, et al. Anti-epileptic and neuroprotective effects of ultra-low dose NADPH oxidase inhibitor dextromethorphan on kainic acid-induced chronic temporal lobe epilepsy in rats. Neurosci Bull 2023, https://doi.org/10.1007/s12264-023-01140-8.CrossRefPubMedPubMedCentral
Yang JJ, Liu YX, Wang YF, Ge BY, Wang Y, Wang QS, et al. Anti-epileptic and neuroprotective effects of ultra-low dose NADPH oxidase inhibitor dextromethorphan on kainic acid-induced chronic temporal lobe epilepsy in rats. Neurosci Bull 2023, https://doi.org/10.1007/s12264-023-01140-8.CrossRefPubMedPubMedCentral
14.
go back to reference Wu PP, Cao BR, Tian FY, Gao ZB. Development of SV2A ligands for epilepsy treatment: a review of levetiracetam, brivaracetam, and padsevonil. Neurosci Bull 2023, https://doi.org/10.1007/s12264-023-01138-2.CrossRefPubMedPubMedCentral
Wu PP, Cao BR, Tian FY, Gao ZB. Development of SV2A ligands for epilepsy treatment: a review of levetiracetam, brivaracetam, and padsevonil. Neurosci Bull 2023, https://doi.org/10.1007/s12264-023-01138-2.CrossRefPubMedPubMedCentral
15.
go back to reference Okoh J, Mays J, Bacq A, Oses-Prieto JA, Tyanova S, Chen CJ, et al. Targeted suppression of mTORC2 reduces seizures across models of epilepsy. Nat Commun 2023, 14: 7364.CrossRefPubMedPubMedCentral
Okoh J, Mays J, Bacq A, Oses-Prieto JA, Tyanova S, Chen CJ, et al. Targeted suppression of mTORC2 reduces seizures across models of epilepsy. Nat Commun 2023, 14: 7364.CrossRefPubMedPubMedCentral
16.
go back to reference Zhang S, Guo X, Huang W, Xu C. mTORC2: the “ace in the hole” for a broader control of epileptic seizures? Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01187-1.CrossRefPubMed
Zhang S, Guo X, Huang W, Xu C. mTORC2: the “ace in the hole” for a broader control of epileptic seizures? Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01187-1.CrossRefPubMed
17.
go back to reference Shen Y, Gong Y, Ruan Y, Chen Z, Xu C. Secondary epileptogenesis: Common to see, but possible to treat? Front Neurol 2021, 12: 747372.CrossRefPubMedPubMedCentral
Shen Y, Gong Y, Ruan Y, Chen Z, Xu C. Secondary epileptogenesis: Common to see, but possible to treat? Front Neurol 2021, 12: 747372.CrossRefPubMedPubMedCentral
18.
go back to reference Xu C, Wang Y, Zhang S, Nao J, Liu Y, Wang Y, et al. Subicular pyramidal neurons gate drug resistance in temporal lobe epilepsy. Ann Neurol 2019, 86: 626–640.CrossRefPubMed
Xu C, Wang Y, Zhang S, Nao J, Liu Y, Wang Y, et al. Subicular pyramidal neurons gate drug resistance in temporal lobe epilepsy. Ann Neurol 2019, 86: 626–640.CrossRefPubMed
19.
go back to reference Ruan Y, Xu C, Lan J, Nao J, Zhang S, Fan F, et al. Low-frequency stimulation at the subiculum is anti-convulsant and anti-drug-resistant in a mouse model of lamotrigine-resistant temporal lobe epilepsy. Neurosci Bull 2020, 36: 654–658.CrossRefPubMedPubMedCentral
Ruan Y, Xu C, Lan J, Nao J, Zhang S, Fan F, et al. Low-frequency stimulation at the subiculum is anti-convulsant and anti-drug-resistant in a mouse model of lamotrigine-resistant temporal lobe epilepsy. Neurosci Bull 2020, 36: 654–658.CrossRefPubMedPubMedCentral
20.
go back to reference Shen Y, Gong Y, Da X, Gao S, Zhang S, Sun M, et al. Low-frequency stimulation at the subiculum prevents extensive secondary epileptogenesis in temporal lobe epilepsy. Neurosci Bull 2024, https://doi.org/10.1007/s12264-023-01173-z.CrossRefPubMedPubMedCentral
Shen Y, Gong Y, Da X, Gao S, Zhang S, Sun M, et al. Low-frequency stimulation at the subiculum prevents extensive secondary epileptogenesis in temporal lobe epilepsy. Neurosci Bull 2024, https://doi.org/10.1007/s12264-023-01173-z.CrossRefPubMedPubMedCentral
21.
go back to reference Kobayashi M, Buckmaster PS. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 2003, 23: 2440–2452.CrossRefPubMedPubMedCentral
Kobayashi M, Buckmaster PS. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 2003, 23: 2440–2452.CrossRefPubMedPubMedCentral
22.
go back to reference Bershteyn M, Bröer S, Parekh M, Maury Y, Havlicek S, Kriks S, et al. Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy. Cell Stem Cell 2023, 30: 1331-1350.e11.CrossRefPubMedPubMedCentral
Bershteyn M, Bröer S, Parekh M, Maury Y, Havlicek S, Kriks S, et al. Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy. Cell Stem Cell 2023, 30: 1331-1350.e11.CrossRefPubMedPubMedCentral
23.
go back to reference Chen J, Li Z, Wang Y, Chen L. GABAergic interneuron cell therapy for drug-resistant epilepsy. Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01195-1.CrossRefPubMed
Chen J, Li Z, Wang Y, Chen L. GABAergic interneuron cell therapy for drug-resistant epilepsy. Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01195-1.CrossRefPubMed
24.
go back to reference Zhou Y, Wang Y, Yang L. Stem Cell Transplantation Represents a New Strategy for the Treatment of Epilepsy. Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01208-z.
Zhou Y, Wang Y, Yang L. Stem Cell Transplantation Represents a New Strategy for the Treatment of Epilepsy. Neurosci Bull 2024, https://doi.org/10.1007/s12264-024-01208-z.
Metadata
- Title
- Novel Mechanism, Drug Target and Therapy in Epilepsy
- Authors
-
Cenglin Xu
Yi Wang
Zhong Chen
- Publication date
- 24-04-2024
- Publisher
- Springer Nature Singapore
- Keywords
- Epilepsy
Dextromethorphan
Brivaracetam - Published in
-
Neuroscience Bulletin
Print ISSN: 1673-7067
Electronic ISSN: 1995-8218 - DOI
- https://doi.org/10.1007/s12264-024-01215-0